Screener
Edwards Lifesciences EW Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on the most recent quarter.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's net debt / EBITDA?
- Edwards Lifesciences (EW) reported net debt / EBITDA of -1.2× in Q1 2026.
- How has Edwards Lifesciences's net debt / EBITDA changed year-over-year?
- Edwards Lifesciences's net debt / EBITDA increased by 25.5% year-over-year, from -1.6× to -1.2×.
- What is the long-term trend for Edwards Lifesciences's net debt / EBITDA?
- Over 5 years (2020 to 2025), Edwards Lifesciences's net debt / EBITDA has grown at a 25.6% compound annual growth rate (CAGR), from -0.5× to -1.6×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Edwards Lifesciences's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude